This company has been marked as potentially delisted and may not be actively trading. Athena Technology Acquisition (ATEK) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOptions ChainOwnershipTrendsBuy This Stock ATEK vs. CRTX, OMCL, HSTM, MDRX, SIMA, HOND, GCL, POLE, JACS, and VCICShould you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), SIM Acquisition Corp. I (SIMA), HCM II Acquisition (HOND), GCL Global (GCL), Andretti Acquisition Corp. II (POLE), Jackson Acquisition Co II (JACS), and Vine Hill Capital Investment (VCIC). Athena Technology Acquisition vs. Cortexyme Omnicell HealthStream Veradigm SIM Acquisition Corp. I HCM II Acquisition GCL Global Andretti Acquisition Corp. II Jackson Acquisition Co II Vine Hill Capital Investment Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, community ranking, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk. Which has preferable valuation & earnings, CRTX or ATEK? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCortexymeN/AN/A-$89.94M-$2.97-0.36Athena Technology AcquisitionN/AN/AN/AN/AN/A Does the media prefer CRTX or ATEK? In the previous week, Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Cortexyme Neutral Athena Technology Acquisition Neutral Does the MarketBeat Community prefer CRTX or ATEK? Athena Technology Acquisition received 478 more outperform votes than Cortexyme when rated by MarketBeat users. However, 64.44% of users gave Cortexyme an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote. CompanyUnderperformOutperformCortexymeOutperform Votes15464.44% Underperform Votes8535.56% Athena Technology AcquisitionOutperform Votes63263.65% Underperform Votes36136.35% Is CRTX or ATEK more profitable? Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.Company Net Margins Return on Equity Return on Assets CortexymeN/A -70.96% -63.53% Athena Technology Acquisition N/A N/A N/A Which has more risk and volatility, CRTX or ATEK? Cortexyme has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Do institutionals and insiders believe in CRTX or ATEK? 63.2% of Cortexyme shares are held by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are held by institutional investors. 27.9% of Cortexyme shares are held by insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryAthena Technology Acquisition beats Cortexyme on 5 of the 8 factors compared between the two stocks. Get Athena Technology Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATEK vs. The Competition Export to ExcelMetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE ExchangeMarket Cap$81.20M$473.41M$2.46B$19.21BDividend YieldN/A7.74%13.16%4.00%P/E RatioN/A2.4110.8833.45Price / SalesN/A54.323,410,846.7229.18Price / CashN/A69.0154.9917.52Price / BookN/A3.663.144.55Net IncomeN/A$35.22M-$305.73M$1.02B Athena Technology Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATEKAthena Technology AcquisitionN/A$8.00flatN/AN/A$81.20MN/A0.002,021CRTXCortexymeN/A$1.10-2.7%N/A+12.5%$33.17MN/A-0.3755OMCLOmnicell2.1715 of 5 stars$31.37+0.4%$50.67+61.5%+6.4%$1.47B$1.11B116.303,800Upcoming EarningsAnalyst DowngradeNews CoveragePositive NewsHSTMHealthStream3.8235 of 5 stars$33.57-0.2%$32.00-4.7%+26.1%$1.02B$291.65M51.641,140Upcoming EarningsPositive NewsMDRXVeradigm2.8366 of 5 stars$4.30+1.2%$14.00+225.6%-43.6%$465.54M$1.53B0.008,000SIMASIM Acquisition Corp. IN/A$10.26+0.1%N/AN/A$314.64MN/A0.00N/ANews CoverageHONDHCM II AcquisitionN/A$10.90flatN/AN/A$313.38MN/A0.00N/ANews CoveragePositive NewsGCLGCL GlobalN/A$2.40flatN/AN/A$303.06M$112.35M0.00N/APOLEAndretti Acquisition Corp. IIN/A$10.22flatN/AN/A$301.59MN/A0.00N/ANews CoveragePositive NewsJACSJackson Acquisition Co IIN/A$10.17+0.2%N/AN/A$300.93MN/A0.002VCICVine Hill Capital InvestmentN/A$10.25+0.3%N/AN/A$300.66MN/A0.00N/ANews CoveragePositive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies CRTX Alternatives OMCL Alternatives HSTM Alternatives MDRX Alternatives SIMA Alternatives HOND Alternatives GCL Alternatives POLE Alternatives JACS Alternatives VCIC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ATEK) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athena Technology Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athena Technology Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.